Table of Contents

1 Study Coverage

• 1.1 Blood Plasma Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Blood Plasma Market Size Growth Rate by Product
  • 1.4.2 Immunoglobulin
  • 1.4.3 Albumin
  • 1.4.4 Protease Inhibitors
  • 1.4.5 Coagulation Factor Concentrates
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global Blood Plasma Market Size Growth Rate by End User
  • 1.5.2 Hospitals and Clinics
  • 1.5.3 Research Laboratories
  • 1.5.4 Academic Institutions
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Blood Plasma Market Size
  • 2.1.1 Global Blood Plasma Revenue 2014-2025
  • 2.1.2 Global Blood Plasma Sales 2014-2025
• 2.2 Blood Plasma Growth Rate by Regions
  • 2.2.1 Global Blood Plasma Sales by Regions
  • 2.2.2 Global Blood Plasma Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Blood Plasma Sales by Manufacturers
  • 3.1.1 Blood Plasma Sales by Manufacturers
  • 3.1.2 Blood Plasma Sales Market Share by Manufacturers
  • 3.1.3 Global Blood Plasma Market Concentration Ratio (CR5 and HHI)
• 3.2 Blood Plasma Revenue by Manufacturers
  • 3.2.1 Blood Plasma Revenue by Manufacturers (2014-2019)
  • 3.2.2 Blood Plasma Revenue Share by Manufacturers (2014-2019)
• 3.3 Blood Plasma Price by Manufacturers
• 3.4 Blood Plasma Manufacturing Base Distribution, Product Types
  • 3.4.1 Blood Plasma Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Blood Plasma Product Type
  • 3.4.3 Date of International Manufacturers Enter into Blood Plasma Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Blood Plasma Sales by Product
• 4.2 Global Blood Plasma Revenue by Product
• 4.3 Blood Plasma Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Blood Plasma Breakdown Data by End User

6 North America

• 6.1 North America Blood Plasma by Countries
  • 6.1.1 North America Blood Plasma Sales by Countries
  • 6.1.2 North America Blood Plasma Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Blood Plasma by Product
• 6.3 North America Blood Plasma by End User

7 Europe

• 7.1 Europe Blood Plasma by Countries
  • 7.1.1 Europe Blood Plasma Sales by Countries
  • 7.1.2 Europe Blood Plasma Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Blood Plasma by Product
• 7.3 Europe Blood Plasma by End User

8 Asia Pacific

• 8.1 Asia Pacific Blood Plasma by Countries
  • 8.1.1 Asia Pacific Blood Plasma Sales by Countries
  • 8.1.2 Asia Pacific Blood Plasma Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Blood Plasma by Product
• 8.3 Asia Pacific Blood Plasma by End User

9 Central & South America

• 9.1 Central & South America Blood Plasma by Countries
  • 9.1.1 Central & South America Blood Plasma Sales by Countries
  • 9.1.2 Central & South America Blood Plasma Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Blood Plasma by Product
• 9.3 Central & South America Blood Plasma by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Blood Plasma by Countries
  • 10.1.1 Middle East and Africa Blood Plasma Sales by Countries
  • 10.1.2 Middle East and Africa Blood Plasma Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Blood Plasma by Product
• 10.3 Middle East and Africa Blood Plasma by End User

11 Company Profiles

• 11.1 Baxter International
  • 11.1.1 Baxter International Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Baxter International Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Baxter International Blood Plasma Products Offered
  • 11.1.5 Baxter International Recent Development
• 11.2 CSL
  • 11.2.1 CSL Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 CSL Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 CSL Blood Plasma Products Offered
  • 11.2.5 CSL Recent Development
• 11.3 Grifols
  • 11.3.1 Grifols Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Grifols Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Grifols Blood Plasma Products Offered
  • 11.3.5 Grifols Recent Development
• 11.4 Octapharma
  • 11.4.1 Octapharma Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Octapharma Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Octapharma Blood Plasma Products Offered
  • 11.4.5 Octapharma Recent Development
• 11.5 ADMA Biologics
  • 11.5.1 ADMA Biologics Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 ADMA Biologics Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 ADMA Biologics Blood Plasma Products Offered
  • 11.5.5 ADMA Biologics Recent Development
• 11.6 Cerus Corp
  • 11.6.1 Cerus Corp Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Cerus Corp Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Cerus Corp Blood Plasma Products Offered
  • 11.6.5 Cerus Corp Recent Development
• 11.7 Sanquin
  • 11.7.1 Sanquin Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Sanquin Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Sanquin Blood Plasma Products Offered
  • 11.7.5 Sanquin Recent Development
• 11.8 Shanghai Raas
  • 11.8.1 Shanghai Raas Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Shanghai Raas Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Shanghai Raas Blood Plasma Products Offered
  • 11.8.5 Shanghai Raas Recent Development
• 11.9 TCS Biosciences
  • 11.9.1 TCS Biosciences Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 TCS Biosciences Blood Plasma Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 TCS Biosciences Blood Plasma Products Offered
  • 11.9.5 TCS Biosciences Recent Development

12 Future Forecast

• 12.1 Blood Plasma Market Forecast by Regions
  • 12.1.1 Global Blood Plasma Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Blood Plasma Revenue Forecast by Regions 2019-2025
• 12.2 Blood Plasma Market Forecast by Product
  • 12.2.1 Global Blood Plasma Sales Forecast by Product 2019-2025
  • 12.2.2 Global Blood Plasma Revenue Forecast by Product 2019-2025
• 12.3 Blood Plasma Market Forecast by End User
• 12.4 North America Blood Plasma Forecast
• 12.5 Europe Blood Plasma Forecast
• 12.6 Asia Pacific Blood Plasma Forecast
• 12.7 Central & South America Blood Plasma Forecast
• 12.8 Middle East and Africa Blood Plasma Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Blood Plasma Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Plasma is the liquid portion of the blood. Plasma is the versatile component and makes about 55% of the blood. Plasma is the composite mixture of more than 700 proteins and other substances which are vital for the efficient functioning of the human body. Plasma helps in regulating body temperature and blood pressure. It serves as a medium for exchange of proteins, nutrients and hormones to the different parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma. Plasma is extracted as proteins and substances and used as main ingredients in medical products to replace body fluids, clotting factors and antibodies. Plasma is used as a component for the treatment of serious health problems such as hemophilia and autoimmune disorders.
North America dominates the global market for blood plasma due to large number of aging population. Asia followed by the Europe is expected to show high growth rates in the next five years in global blood plasma market. China is expected to be the fastest growing blood plasma markets in Asia region. Some of the key driving forces for blood plasma market in emerging countries are large pool of patients and rising government funding. 
The global Blood Plasma market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Blood Plasma market based on company, product type, end user and key regions.

This report studies the global market size of Blood Plasma in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Blood Plasma in these regions.
This research report categorizes the global Blood Plasma market by top players/brands, region, type and end user. This report also studies the global Blood Plasma market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter International
CSL
Grifols
Octapharma
ADMA Biologics
Cerus Corp
Sanquin
Shanghai Raas
TCS Biosciences

Market size by Product
Immunoglobulin
Albumin
Protease Inhibitors
Coagulation Factor Concentrates
Others
Market size by End User
Hospitals and Clinics
Research Laboratories
Academic Institutions

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Blood Plasma market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Blood Plasma market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Blood Plasma companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Blood Plasma submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Blood Plasma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Blood Plasma market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.